ASX:IMM
Immutep Limited
- Stock
locale
Australiamarket
STOCKSindustry
Biotechnologywebsite
www.immutep.comipo date
Jun 30, 1988
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemo-immunotherapy combination for meta...Show More
Earnings
Earnings Release TomorrowEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus